490 Clinical benefit through Siglec-15 targeting with NC318 antibody in subjects with Siglec-15 positive advanced solid tumors

• Omid Hamid,
• Anthony Tolcher,
• Martin Gutierrez,
• Elaine Shum,
• Linda Liu,
• Solomon Langermann,
• Zachary Cusumano,
• Han Myint,
• Jahangheer Shaik,
• Emilia Barbu,
• Qinjie Zhou,
• Aaron Morawski,
• Hasan Abukharma,
• Megan Nelson,
• Stephanie Zeidan

Affiliations

Omid Hamid

Cedars-Sinai Medical Center Angeles Clinic and Research Institute, Santa Monica, California, USA

Anthony Tolcher

6Next Onoclogy, San Antonio, TX, USA

Martin Gutierrez

Hackensack University Medical Center, Hackensack, New Jersey, USA

Elaine Shum

1New York University, New York, NY, USA

Linda Liu

2NextCure, Beltsville, MD, USA

Solomon Langermann

2NextCure, Beltsville, MD, USA

Zachary Cusumano

1NextCure, Inc., Beltsville, MD, USA

Han Myint

1NextCure LLC, Beltsville, MD, USA

Jahangheer Shaik

1NextCure LLC, Beltsville, MD, USA

Emilia Barbu

1NextCure LLC, Beltsville, MD, USA

Qinjie Zhou

1NextCure LLC, Beltsville, MD, USA

Aaron Morawski

1NextCure LLC, Beltsville, MD, USA

Hasan Abukharma

1NextCure LLC, Beltsville, MD, USA

Megan Nelson

1NextCure LLC, Beltsville, MD, USA

Stephanie Zeidan

1NextCure LLC, Beltsville, MD, USA